Xenogeneic Murine Tyrosinase DNA Vaccine for Malignant Melanoma of the Digit of Dogs

Journal of Veterinary Internal Medicine

Volumn 25, Issue 1, 2011, Pages 94-99

  Manley, C A ^a   Leibman, N F ^a   Wolchok, J D ^b   Riviere I C ^b   Bartido, S ^b   Craft, D M ^a   Bergman, P J ^a  

^a ANIMAL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Melanoma staging; Subungual; Tumor immunotherapy

Indexed keywords

CANCER VACCINE; DNA VACCINE; MONOPHENOL MONOOXYGENASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CANCER STAGING; COHORT ANALYSIS; DOG; DOG DISEASE; FEMALE; GENETICS; IMMUNOLOGY; KAPLAN MEIER METHOD; MALE; MELANOMA; METHODOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SKIN TUMOR;

ANIMALS; CANCER VACCINES; COHORT STUDIES; DOG DISEASES; DOGS; FEMALE; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MONOPHENOL MONOOXYGENASE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; VACCINES, DNA;

ANIMALIA; CANIS FAMILIARIS; MURINAE;

EID: 78651261768     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0627.x     Document Type: Article

References (19)

1. MacEwen EG, Patnaik AK, Harvey HJ, et al. Canine oral melanoma: Comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Invest 1986;4:397-402.
2. Marino DJ, Matthiesen DT, Stefanacci JD, et al. Evaluation of dogs with digit masses: 117 cases (1981-1991). J Am Vet Med Assoc 1995;207:726-728.
3. Henry CJ, Brewer WG, Whitley EM, et al. Canine digital tumors: A veterinary cooperative oncology group retrospective study of 64 dogs. J Vet Intern Med 2005;19:720-724.
4. Schultheiss PC. Histologic features and clinical outcomes of melanoma of lip, haired skin, and nail bed locations of dogs. J Vet Diagn Invest 2006;18:422-425.
5. Spangler WL, Kass PH. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol 2006;43:136-149.
6. Wobeser BK, Kidney BA, Powers BE, et al. Diagnoses and clinical outcomes associated with surgically amputated canine digits submitted to multiple veterinary diagnostic laboratories. Vet Pathol 2007;44:355-361.
7. Arohnson MG, Carpenter JL. Distal extremity melanocytic nevi and malignant melanomas in dogs. J Am Anim Hosp Assoc 1990;26:605-612.
8. Proulx DR, Ruslander DM, Dodge RK, et al. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound 2003;44:352-359.
9. Murphy S, Hayes AM, Blackwood L, et al. Oral malignant melanoma-the effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy. Vet Comp Oncol 2005;3:222-229.
10. Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005;6:185-193.
11. Bergman PJ, McKnight JA, Novosad A, et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: A phase I trial. Clin Cancer Res 2003;9:1284-1290.
12. Bergman PJ, Camps-Palau MA, McKnight JA, et al. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 2006;24:4582-4585.
13. Weber LW, Bowne WB, Wolchok JD, et al. Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest 1998;102:1258-1264.
14. Liao JC, Gregor P, Wolchok JD, et al. Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma. Cancer Immun 2007;6:1-10.
15. Goubier A, Fuhrman L. Superiority of needle-free transdermal plasmid delivery for the induction of antigen-specific IFNgamma T cell responses in the dog. Vaccine 2008;26:2186-2190.
16. Owen LN. TNM Classification of Tumors in Domestic Animals. Geneva, Switzerland: World Health Organization; 1980.
17. Bouchard B, Fuller BB, Vijayasaradhi S, et al. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J Exp Med 1989;169:2029-2042.
18. Bergman PJ, Wolchok JD. Of mice and men (and dogs): Development of a xenogeneic DNA vaccine for canine oral malignant melanoma. Cancer Therapy 2008;6:817-826.
19. Laprie C, Abadie J, Amardeilh MF, et al. MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma. Vet Dermatol 2001;12:139-147.